Company Analysis

CalciMedica, Inc. (CALC)

Nasdaq: CALC · Pharmaceutical Preparations · La Jolla, CA · filing with the SEC since 2011
Grade4.3
◀ Past 2.7● Present 3.3▶ Future 6.2
7 est.

Who owns CalciMedica, Inc.

As filed with the SEC
Holders of 5% or more
7
Alafi Capital Company LLC holds 19.9% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13D/A filed Aug 24, 2026 says.
Directors and officers
12
report now, of 25 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 7 named at left.
Holders of 5% or moreshare of the class, as filed
Alafi Capital Company LLC
SCHEDULE 13D/A · filed Aug 24, 2026 · Common Stock, par value $0.0001 per share · 17.1% in Jul 10, 2026
19.9%
Bering Partners II GP, L.L.C.
SCHEDULE 13D/A · filed Aug 21, 2026 · Common Stock, par value $0.0001 per share · 6.9% in Jul 2, 2026
9.99%
Armistice Capital, LLC
SCHEDULE 13G · filed Aug 14, 2026 · Common Stock, par value $0.0001 per share
9.99%
Woodline Partners LP
SCHEDULE 13G · filed Aug 14, 2026 · Common Stock, par value $0.0001 per share
8.1%
Eric W. Roberts
SCHEDULE 13D/A · filed Jun 30, 2026 · Common Stock, par value $0.0001 per share
6.4%
Stonepine Capital Management, LLC
SCHEDULE 13G · filed Aug 25, 2026 · Common Stock · 4.6% in May 14, 2025
6%
CVI Investments, Inc.
SCHEDULE 13G · filed Jul 20, 2026 · Common Stock, $0.0001 par value per share
5.1%
Avenue Venture Opportunities Fund II, L.P.
SCHEDULE 13G/A · filed Jun 25, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 8.87% in Sep 9, 2025
under 5%
Deerfield Mgmt, L.P.
SCHEDULE 13G/A · filed Feb 6, 2026 · Common Stock · reported falling below 5%
under 5%
Aisling Capital V, LP
SCHEDULE 13G/A · filed Mar 3, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%
under 5%
Soleus Capital Management, L.P.
SCHEDULE 13G/A · filed May 8, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 7.5% in Nov 7, 2025
under 5%
Chernett Jorey
SCHEDULE 13G/A · filed May 20, 2026 · Common Stock, $0.0001 Par Value Per Share · reported falling below 5%, from 7.9% in Dec 1, 2025
under 5%
Revelation Healthcare Fund I, L.P.
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, $0.0001 par value per share · reported falling below 5%
under 5%
What CALC reports owning in othersstakes of 5% or more, and other ties

2 subsidiaries in 1 country, from the list filed with the 10-K filed Mar 28, 2024.

Insider tradesForm 4
0sales
1purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$200,000bought, in dollars
Open-market trades on Form 4 from Nov 5, 2025 to Nov 5, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
20212223242526
2026 runs to Nov 5, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 45 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Middleton Fred Adirector0$001$200,000
SI Assistanton CALC · research, not advice